60- Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.

Drug Saf. 2020 Dec;43(12):1315-1322. doi: 10.1007/s40264-020-01013-3.